Neurosurgeon Dr. Klaas Bakker joins Oncopeptides as CMO

Written by Alan Condon | August 20, 2019 | Print  |

Klass Bakker, MD, PhD, was appointed as the new CMO of pharmaceutical company Oncopeptides.

Four things to know:

1. Dr. Klaas is a board-certified neurosurgeon from the University of Groningen in the Netherlands.

2. Oncopeptides focuses on the development of therapies for hematological cancers.

3. Dr. Klaas has a PhD in immune-hematology and has authored over 40 publications in international peer-reviewed journals.

4. He replaces Johan Harmenberg as CMO, who will remain as a member of the company's medical team.

More articles on devices:
Dr. Adam Bruggeman: A spine surgeon's most important OR trait and bundled benchmarks in spine
Optim Orthopedics welcomes Dr. Thomas Niemeier

7 hospitals expanding spine, neurosurgery programs



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months